BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Biota Pharmaceuticals, Inc. Commences Dosing In Vapendavir SPIRITUS Phase IIb Trial

  March 3, 2015

   · 

  4 min read
• Genetown

  Tesaro, Inc. Announces Proposed Public Offering Of Common Stock

  March 3, 2015

   · 

  2 min read
• Drug Development

  DURECT Corporation Announces Epigenomic Regulator Program Including A New NAFLD/NASH And Acute Organ Injury Product Candidate In Development

  March 3, 2015

   · 

  7 min read
• Business

  Vision RT Appoints Henrik Andersen As VP Sales, EMEA And Asia Pacific

  March 3, 2015

   · 

  2 min read
• Drug Development

  MyoKardia Announces Initiation Of Phase 1 Clinical Study Of MYK-461 For Hypertrophic Cardiomyopathy

  March 3, 2015

   · 

  6 min read
• ORYX To Present At Sachs European Life Science CEO Forum And Exhibition

  March 3, 2015

   · 

  1 min read
• Galectin Therapeutics To Present At The 27th Annual ROTH Conference

  March 3, 2015

   · 

  1 min read
• Affimed Therapeutics AG To Present At The 27th Annual ROTH Conference

  March 3, 2015

   · 

  3 min read
• BioForest

  Galena Biopharma To Present At The 27th Annual ROTH Conference

  March 3, 2015

   · 

  1 min read
• Business

  Halozyme Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results

  March 3, 2015

   · 

  5 min read